Canchemia Inc.
Canchemia Inc. is a privately held Canadian B2B chemical supplier that provides raw materials, intermediates, APIs, and fine chemicals to pharmaceutical and specialty chemical buyers across North America, leveraging in-house laboratories, pilot plants, commercial manufacturing, and a China-based sourcing team.
- Company typePrivate
- Founded-
- HeadquartersToronto, Canada
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Canchemia Inc. does
Canchemia Inc. (also branded CanChemia) is a privately held Canadian company headquartered at Unit 609, 5 Liszt Gate, Toronto, Ontario. The company supplies raw materials, intermediates, active pharmaceutical ingredients (APIs), and fine chemicals to the pharmaceutical and specialty chemical industries in North America. Its stated value proposition is competitive pricing combined with quality and timeline reliability, supported by an integrated supply chain that pairs in-house developmental laboratories, pilot plants, and commercial manufacturing capabilities with a dedicated sourcing team in China. The company publicly commits to Responsible Care principles for safe chemical handling and processing.
Canchemia operates a direct B2B distribution model, selling chemicals through direct sales to pharmaceutical and specialty chemical buyers across North America. Its primary digital presence is on the LookChem B2B chemical marketplace, where it currently lists two products: 5-Ethyl-2-pyridineethanol (CAS 5223-6-3) and Thiazolidine, 2,2-dimethyl-, hydrochloride (CAS 822-44-6), both pharmaceutical intermediates with documented CAS numbers, molecular formulas, and 99% purity specifications. Pricing is handled through direct supplier contact rather than published tiers, and minimum order quantities and payment terms are not publicly disclosed.
The company's underlying platform architecture is its integrated manufacturing-plus-sourcing structure: developmental labs and pilot plants enable process development and small-batch work, while commercial manufacturing and the China sourcing team enable scale and cost-competitive procurement. Ownership appears to be independent and closely held, with no institutional investors, parent companies, or venture backing disclosed in the source material. Revenue, headcount, founding date, certifications, and management team details are not publicly documented in the inputs provided.
Canchemia Inc. firmographics
Firmographics- Name
- Canchemia Inc.
- Legal name
- Canchemia Inc.
- Website
- https://canchemia.lookchem.com
- Company type
- Private
- Operating status
- Operating
- Short description
- Canchemia Inc. is a privately held Canadian B2B chemical supplier that provides raw materials, intermediates, APIs, and fine chemicals to pharmaceutical and specialty chemical buyers across North America, leveraging in-house laboratories, pilot plants, commercial manufacturing, and a China-based sourcing team.
- Ownership category
- akta.pro rank
Where Canchemia Inc. is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Canchemia Inc. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Chemical Product Sales: Revenue generated from the sale of raw materials, intermediates, Active Pharmaceutical Ingredients (APIs), and fine chemicals to pharmaceutical and specialty chemical industry customers in North America.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Canchemia Inc. product offering
Product offeringCore offering
Canchemia Inc. is a Canadian supplier of raw materials, intermediates, Active Pharmaceutical Ingredients (APIs), and fine chemicals serving the pharmaceutical and specialty chemical industries in North America. The company combines in-house developmental laboratories, pilot plants, and commercial manufacturing facilities with a China-based sourcing team to deliver products with superior timeline, quality, and pricing. It operates under Responsible Care principles for safe chemical handling and processing.
Product overview
Canchemia Inc. operates as a chemical raw materials supplier offering a focused portfolio of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company supplies two main chemical compounds: 5-Ethyl-2-pyridineethanol (CAS 5223-6-3) and Thiazolidine, 2,2-dimethyl-, hydrochloride (CAS 822-44-6). These products are sold as raw materials and intermediates for the pharmaceutical and specialty chemical industries in North America, distributed through the LookChem marketplace platform.
Differentiator
Problem solved
Functional benefit
Products and services
- 5-Ethyl-2-pyridineethanol Pharmaceutical intermediate with CAS No. 5223-6-3 and molecular formula C9H13NO. Sold as a raw material for pharmaceutical and specialty chemical manufacturing, with 99% purity and packaging according to client requirements.
- Thiazolidine, 2,2-dimethyl-, hydrochloride Pharmaceutical intermediate with CAS No. 822-44-6 and molecular formula C5H12ClNS. Sold at 99% purity as a raw material for pharmaceutical manufacturing, with packaging per client requirement and transportation by sea or air.
Companies that use Canchemia Inc.
Customer profileSegments2 records
Ideal customer profiles2 records
Canchemia Inc. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Canchemia Inc. partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- China Sourcing TeamcoreInternal sourcing team based in China that establishes and maintains solid cooperation with overseas customers and suppliers to support the company's chemical supply operations.
Scale indicators1 record
Recent moves4 records
Expansion highlights2 records
Canchemia Inc. competitors and assessment
Company assessmentDirect peers
- Alfa Chemistry: Online-first chemicals supplier offering intermediates, APIs, and fine chemicals to research and industrial buyers. Comparable marketplace-led GTM and pharmaceutical intermediate product mix.
- Santa Cruz Biotechnology: Supplier of research chemicals, biochemicals, and pharmaceutical intermediates. Comparable B2B distribution to pharma and life sciences buyers with broad chemical intermediate offerings.
- Toronto Research Chemicals: Canadian supplier of specialty organic chemicals, including pharmaceutical intermediates and reference standards. Highly comparable to Canchemia in geography, product category, and customer base in North American pharma R&D.
- TCI Chemicals (Tokyo Chemical Industry): Global specialty chemicals supplier with deep catalog of pharmaceutical intermediates, APIs, and fine chemicals. Directly comparable in product category, customer base, and B2B distribution model.
- Combi-Blocks: US-based supplier of chemical building blocks, intermediates, and APIs to pharmaceutical and biotech customers. Overlaps with Canchemia on intermediate/API supply and pharma buyer base.
Broad incumbents
- Johnson Matthey: Specialty chemicals company with pharmaceutical materials, catalysts, and fine chemicals offerings. Comparable product category but operates as a diversified incumbent serving global pharma and industrial customers.
- Sigma-Aldrich (Merck KGaA): Global incumbent in research and specialty chemicals, including pharmaceutical intermediates and APIs under the Sigma-Aldrich brand. Overlaps with Canchemia on product category but serves far broader portfolio and geography.
- Thermo Fisher Scientific: Diversified life sciences and laboratory products supplier offering chemicals, intermediates, and pharma services. Competes with Canchemia for pharma and specialty chemical procurement budgets but as part of a much wider portfolio.
- BASF: Global chemical giant with significant pharmaceutical ingredients and intermediates business. Overlaps with Canchemia on fine chemicals and APIs but operates at vastly larger scale with broad product portfolio.
Others
- Pfizer CentreOne: Contract development and manufacturing organization (CDMO) offering API and intermediate supply to the pharma industry. Adjacent rather than directly competitive - represents the type of integrated service model Canchemia could evolve toward.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat2 records
Key risks6 records
Key highlights5 records
Customer concentration
Canchemia Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Canchemia Inc. leadership team
Management profileNumber of profiles
Profiles1 record
Canchemia Inc. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Canchemia Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Canchemia Inc.
What does Canchemia Inc. do?
Canchemia Inc. is a Canadian supplier of raw materials, intermediates, Active Pharmaceutical Ingredients (APIs), and fine chemicals serving the pharmaceutical and specialty chemical industries in North America. The company combines in-house developmental laboratories, pilot plants, and commercial manufacturing facilities with a China-based sourcing team to deliver products with superior timeline, quality, and pricing. It operates under Responsible Care principles for safe chemical handling and processing.
When was Canchemia Inc. founded?
Canchemia Inc. was founded in -1.
Where is Canchemia Inc. based?
Canchemia Inc. is headquartered in Toronto, Canada, in the North America region.
How does Canchemia Inc. make money?
One revenue line is on record: chemical Product Sales.
Who are Canchemia Inc.'s main competitors?
Direct peers on record are Alfa Chemistry, Santa Cruz Biotechnology, Toronto Research Chemicals, TCI Chemicals (Tokyo Chemical Industry) and Combi-Blocks. Broad incumbents are Johnson Matthey, Sigma-Aldrich (Merck KGaA), Thermo Fisher Scientific and BASF. Pfizer CentreOne is listed as an others.
Does Canchemia Inc. have an API?
No public API is recorded for Canchemia Inc..